Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study

Abstract In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C virus (HCV) infection decreased substantially after the introduction of direct-acting antivirals (DAAs). Among men who have sex with men, the increase in DAA uptake and efficacy was counterbalanced by frequent incident HCV infections.

[1]  C. Boucher,et al.  Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  E. Bernasconi,et al.  Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[3]  H. Günthard,et al.  On the potential of a short‐term intensive intervention to interrupt HCV transmission in HIV‐positive men who have sex with men: A mathematical modelling study , 2018, Journal of viral hepatitis.

[4]  A. d’Arminio Monforte,et al.  Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990-2014. , 2017, Journal of hepatology.

[5]  G. Dore,et al.  HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs , 2017, Current HIV/AIDS Reports.

[6]  H. Stellbrink,et al.  HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe. , 2017, Journal of hepatology.

[7]  J. Rockstroh,et al.  Effect of coinfection with hepatitis C virus on survival of individuals with HIV-1 infection , 2016, Current opinion in HIV and AIDS.

[8]  M. Egger,et al.  Hepatitis C virus transmission among human immunodeficiency virus‐infected men who have sex with men: Modeling the effect of behavioral and treatment interventions , 2016, Hepatology.

[9]  C. Sabin,et al.  Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  G. Cooke,et al.  Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Vickerman,et al.  Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  H. Günthard,et al.  Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.